Amphastar Pharmaceuticals Inc (AMPH)
43.48
+0.74
(+1.73%)
USD |
NASDAQ |
May 17, 16:00
43.50
+0.02
(+0.05%)
After-Hours: 20:00
Amphastar Pharmaceuticals Total Return Level: 43.48 for May 17, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 17, 2024 | 43.48 |
May 16, 2024 | 42.74 |
May 15, 2024 | 42.44 |
May 14, 2024 | 41.30 |
May 13, 2024 | 42.37 |
May 10, 2024 | 42.21 |
May 09, 2024 | 42.43 |
May 08, 2024 | 42.21 |
May 07, 2024 | 42.77 |
May 06, 2024 | 42.68 |
May 03, 2024 | 42.46 |
May 02, 2024 | 42.66 |
May 01, 2024 | 42.08 |
April 30, 2024 | 41.25 |
April 29, 2024 | 42.02 |
April 26, 2024 | 41.11 |
April 25, 2024 | 40.83 |
April 24, 2024 | 41.00 |
April 23, 2024 | 40.91 |
April 22, 2024 | 40.17 |
April 19, 2024 | 40.01 |
April 18, 2024 | 38.65 |
April 17, 2024 | 40.05 |
April 16, 2024 | 40.90 |
April 15, 2024 | 40.78 |
Date | Value |
---|---|
April 12, 2024 | 39.62 |
April 11, 2024 | 40.15 |
April 10, 2024 | 40.05 |
April 09, 2024 | 40.90 |
April 08, 2024 | 41.05 |
April 05, 2024 | 41.79 |
April 04, 2024 | 41.52 |
April 03, 2024 | 41.94 |
April 02, 2024 | 42.32 |
April 01, 2024 | 43.44 |
March 28, 2024 | 43.91 |
March 27, 2024 | 43.52 |
March 26, 2024 | 43.21 |
March 25, 2024 | 43.63 |
March 22, 2024 | 43.70 |
March 21, 2024 | 44.53 |
March 20, 2024 | 44.03 |
March 19, 2024 | 44.57 |
March 18, 2024 | 42.85 |
March 15, 2024 | 43.05 |
March 14, 2024 | 43.19 |
March 13, 2024 | 43.55 |
March 12, 2024 | 44.15 |
March 11, 2024 | 43.81 |
March 08, 2024 | 45.67 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
12.66
Minimum
Mar 20 2020
65.00
Maximum
Aug 08 2023
29.25
Average
21.69
Median
Aug 28 2019
Total Return Level Benchmarks
Eli Lilly and Co | 2220.06 |
Dentsply Sirona Inc | 34.89 |
Pacira BioSciences Inc | 30.82 |
Corvus Pharmaceuticals Inc | 2.29 |
Organon & Co | 25.15 |